The Hsp90 inhibitor IPI-504 rapidly lowers EML4–ALK levels and induces tumor regression in ALK-driven NSCLC models
暂无分享,去创建一个
K. Robison | K. West | V. Palombella | C. Fritz | A. Wylie | C. Tunkey | A. Lim | E. Normant | K. Slocum | J. McDougall | G. Paez | K. Caliri